隐球菌性脑膜炎症状复发:多病因诊断难题的特征分析
研究前瞻性纳入乌干达隐球菌性脑膜炎患者,将第二 episode 症状复发独立裁定为微生物学复发、矛盾性免疫重建炎症综合征(IRIS)、单纯颅内压持续升高或单纯症状持续,并与原发性隐球菌性脑膜炎对照比较。培养阳性复发者CD4和脑脊液白细胞计数低于矛盾性IRIS,作者认为这些易得实验室指标应促使在等待培养结果时启动抗真菌治疗。
要点
- 培养阳性复发者CD4中位数25 cells/μL、脑脊液WBC中位数4 cells/μL,均低于矛盾性IRIS的78 cells/μL和45 cells/μL。
- 脑脊液WBC<5 cells/μL者中86%(43/50)为复发,CD4<50 cells/μL者中91%(39/43)为复发。
- 18周死亡率:原发性隐球菌性脑膜炎47%、培养阳性复发31%、矛盾性IRIS 14%。
核心结论
- 培养阳性复发者较矛盾性IRIS更常出现免疫重建不良,表现为更低的脑脊液WBC和血CD4计数。
- 作者认为这些易获得的实验室值应促使在等待培养结果时启动抗真菌治疗。
研究设计与样本
- 前瞻性纳入乌干达隐球菌性脑膜炎患者,收集患者特征、抗逆转录病毒治疗(ART)及隐球菌病史、临床结局和脑脊液分析结果。
- 共纳入724例参与者:原发性607例、复发81例、矛盾性IRIS 28例、单纯颅内压持续升高2例、单纯症状持续6例。
- 对第二 episode 脑膜炎病例独立裁定分为微生物学复发、矛盾性IRIS、单纯颅内压持续升高或单纯症状持续,并与原发性隐球菌性脑膜炎对照。
- 采用卡方检验或Kruskal-Wallis检验进行组间比较。
- 临床试验注册号NCT01802385。
主要发现
- 培养阳性复发者CD4中位数25 cells/μL(IQR 9-76),低于矛盾性IRIS的78 cells/μL(IQR 47-142)。
- 培养阳性复发者脑脊液WBC中位数4 cells/μL(IQR 4-85),低于矛盾性IRIS的45 cells/μL(IQR 8-128)。
- 脑脊液WBC<5 cells/μL者中86%(43/50)为复发。
- CD4计数<50 cells/μL者中91%(39/43)为复发。
- 自当前症状出现起18周死亡率:原发性隐球菌性脑膜炎47%、培养阳性复发31%、矛盾性IRIS 14%。
关键数值与推荐
- 脑脊液WBC<5 cells/μL者中86%(43/50)为复发。
- CD4计数<50 cells/μL者中91%(39/43)为复发。
临床怎么用
- 作者认为这些易获得的实验室值应促使在等待培养结果时启动抗真菌治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cryptococcal meningitis is a common cause of AIDS-related mortality. Although symptom recurrence after initial treatment is common, the etiology is often difficult to decipher. We sought to summarize characteristics, etiologies, and outcomes among persons with second-episode symptomatic recurrence. METHODS: We prospectively enrolled Ugandans with cryptococcal meningitis and obtained patient characteristics, antiretroviral therapy (ART) and cryptococcosis histories, clinical outcomes, and cerebrospinal fluid (CSF) analysis results. We independently adjudicated cases of second-episode meningitis to categorize patients as (1) microbiological relapse, (2) paradoxical immune reconstitution inflammatory syndrome (IRIS), (3) persistent elevated intracranial pressure (ICP) only, or (4) persistent symptoms only, along with controls of primary cryptococcal meningitis. We compared groups with chi-square or Kruskal-Wallis tests as appropriate. RESULTS: 724 participants were included (n = 607 primary episode, 81 relapse, 28 paradoxical IRIS, 2 persistently elevated ICP, 6 persistent symptoms). Participants with culture-positive relapse had lower CD4 (25 cells/μL; IQR: 9-76) and lower CSF white blood cell (WBC; 4 cells/μL; IQR: 4-85) counts than paradoxical IRIS (CD4: 78 cells/μL; IQR: 47-142; WBC: 45 cells/μL; IQR: 8-128). Among those with CSF WBC <5 cells/μL, 86% (43/50) had relapse. Among those with CD4 counts <50 cells/μL, 91% (39/43) had relapse. Eighteen-week mortality (from current symptom onset) was 47% among first episodes of cryptococcal meningitis, 31% in culture-positive relapses, and 14% in paradoxical IRIS. CONCLUSIONS: Poor immune reconstitution was noted more often in relapse than IRIS as evidenced by lower CSF WBC and blood CD4 counts. These easily obtained laboratory values should prompt initiation of antifungal treatment while awaiting culture results. CLINICAL TRIALS REGISTRATION: NCT01802385.
引用
- Bahr NC, Skipper CP, Huppler-Hullsiek K, et al. Recurrence of Symptoms Following Cryptococcal Meningitis: Characterizing a Diagnostic Conundrum With Multiple Etiologies. Clin Infect Dis. 2023. PMID: 36303432. doi:10.1093/cid/ciac853
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。